ECONOMIC OUTCOMES AND REAL-WORLD ADHERENCE OF PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES TREATED WITH L-GLUTAMINE, VOXELOTOR, AND CRIZANLIZUMAB IN THE UNITED STATES

被引:0
|
作者
Udeze, C. [1 ]
Jerry, M. [2 ]
Evans, K. [2 ]
Li, N. [1 ]
Jain, S. [1 ]
Andemariam, B. [3 ]
机构
[1] Vertex Pharmaceut Inc, Boston, MA USA
[2] Merative, Ann Arbor, MI USA
[3] Univ Connecticut Hlth, Farmington, CT USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE132
引用
收藏
页码:S81 / S81
页数:1
相关论文
共 50 条
  • [31] Real-World Experience of Patients With Sickle Cell Disease Treated With Voxelotor: A Multicenter, Retrospective Study
    Andemariam, Biree
    Osunkwo, Ifeyinwa
    Idowu, Modupe
    Shah, Nirmish
    Drachtman, Richard
    Sharma, Archana
    Glaros, Alexander
    Achebe, Maureen
    Nero, Alecia
    Curtis, Susanna
    Minniti, Caterina
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 134 - 135
  • [32] Real-World Experience of Patients with Sickle Cell Disease Treated with Voxelotor: A Multicenter, Retrospective Study
    Andemariam, Biree
    Achebe, Maureen
    Clay, E. Leila Jerome
    Drachtman, Richard A.
    Sharma, Archana
    Nero, Alecia C.
    Osunkwo, Ifeyinwa
    Sarnaik, Sharada
    Idowu, Modupe
    Shah, Nirmish
    Curtis, Susanna A.
    Minniti, Caterina
    [J]. BLOOD, 2021, 138
  • [33] The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial
    Smith, Wally R.
    Ataga, Kenneth I.
    Saraf, Santosh L.
    Adisa, Olufolake A.
    Bailey, Miranda
    Ramscar, Nicholas
    Bonner, Ashley
    Brown, Stephen
    Pastor, Laura
    [J]. BLOOD, 2020, 136
  • [34] Incidence of Vaso-occlusive crisis and setting of Care in Patients with sickle cell disease from 2013 through 2017 in the United States
    Schachterle, Stephen E.
    Rubinstein, Emily
    Mo, Jingping
    Bate, Andrew
    Gong, Richard
    Sivamurthy, Krupa M.
    Shafer, Frank
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 258 - 259
  • [35] Real-World Experience of Patients with Sickle Cell Disease Treated with Crizanlizumab: A Single Comprehensive Sickle Cell Center Retrospective Cohort Analysis
    Chan, Kok Hoe
    Buddharaju, Ruhi
    Chang, Shandel L.
    Lane, John S.
    Idowu, Modupe
    [J]. BLOOD, 2022, 140 : 8288 - 8289
  • [36] Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients
    Elenga, Narcisse
    Loko, Gylna
    Etienne-Julan, Maryse
    Al-Okka, Randa
    Adel, Ahmad M.
    Yassin, Mohamed A.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [37] Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States
    Herring, William L.
    Gallagher, Meghan E.
    Shah, Nirmish
    Morse, Kc
    Mladsi, Deirdre
    Dong, Olivia M.
    Chawla, Anjulika
    Leiding, Jennifer W.
    Zhang, Lixin
    Paramore, Clark
    Andemariam, Biree
    [J]. PHARMACOECONOMICS, 2024, 42 (06) : 693 - 714
  • [38] MODEL-PROJECTED LONG-TERM CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENEEDITED THERAPY IN PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE UNITED KINGDOM
    Lopez, A.
    Jeyakumar, S.
    Xie, Y.
    Yang, H.
    Li, N.
    Fattah, D.
    Howard, J.
    Wang, J.
    Udeze, C.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S104 - S104
  • [39] Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)
    Abboud, Miguel R.
    Howard, Jo
    Cancado, Rodolfo
    Smith, Wally R.
    Guvenc, Birol
    Espurz, Noemi
    Weill, Marine
    de Montalembert, Mariane
    [J]. BLOOD, 2019, 134
  • [40] Pharmacokinetics/Pharmacodynamics, Safety and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease and a History of Vaso-Occlusive Crises: Results from the Phase II, Multicenter, Open-Label Solace-Adults Study
    Liles, Darla
    Smith-Whitley, Kim
    Brown, R. Clark
    Shah, Nirmish
    Nair, Santosh M.
    Tanaka, Chiaki
    Bodla, Shankaranand
    Sanchez-Olle, Gessami
    Albers, Urs
    Kanter, Julie
    [J]. BLOOD, 2020, 136